Delivering a potent cancer drug with nanoparticles can lessen side effects
The new nanoparticle, which delivers the drug in a form activated when it reaches its target, also treats tumors more effectively than the unadorned drug in mice.
A new approach to bladder-disease treatment
Implanted device can release slow, steady dose of medicine over extended period, removing the need for repeated procedures.
Timing is everything for cancer protein p53
Biologists find that restoring the gene for p53 can slow the spread of advanced lung tumors, but doesn’t help early-stage cancers.
Slideshow: the Koch Institute transforms East Campus environs
Completion of cancer-research building opens green space for community use and creates vibrant streetscape.
Direct delivery
Cancer scientists believe nanoparticles could accurately target tumors, avoiding side effects.
Using the body’s own defenses to combat cancer
By engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.
Turning off cancer genes
RNA interference holds much promise as a cancer treatment, but technical challenges remain.
A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
A new target for cancer drugs
Shutting down an enzyme that responds to DNA damage could boost the effects of traditional chemotherapy.
More than just a pretty flower
MIT chemists engineer the periwinkle plant to produce compounds that could become more effective cancer drugs.
Cancer’s hiding spots revealed
Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse.
New Koch Institute building to open soon
Researchers will start moving into the 365,000-square-foot building next week.
MIT Medical promotes employee mammograms
No referral or copay for female employees between 40 and 70 who are enrolled in any MIT-sponsored health-insurance plan.
Surprising similarities between human and zebrafish tumors
New finding that tumor cells in both species have too many chromosomes could help pinpoint genes that drive cancer development.
New nanoparticles could improve cancer treatment
Particles can deliver a combination of chemotherapy drugs directly to prostate-cancer cells.